RPRX- Royalty Pharma Plc

Name: Royalty Pharma Plc Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Royalty Pharma Plc (RPRX) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 26 sells. RPRX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Legorreta Pablo G.	941.0K	$47.24M	-
VP	Hite Christopher	658.5K	$33.06M	-
Dir	Norden Gregory	194.8K	$9.78M	-
Dir	Desouza Errol B	81.4K	$4.08M	-
?	Bassler Bonnie L	73.1K	$3.67M	-

Activity

Buys and sells only

Transactions

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Dec 3, 2025	Lloyd George W.71	EVP, Investments &CLO	Sell	110,000	$39.77	$4,375,008.00	-50.0%	+19.9%	-
Dec 1, 2025	Coyne Terrance P.75	EVP &CFO	Sell	69,582	$39.87	$2,773,956.01	-9.8%	+19.0%	-
Dec 1, 2025	Urist Marshall73	EVP, Research &Investments	Sell	41,575	$39.92	$1,659,488.82	-16.6%	+19.0%	-
Nov 24, 2025	Coyne Terrance P.75	EVP &CFO	Sell	69,582	$38.55	$2,682,505.45	-4.6%	+14.4%	-
Nov 19, 2025	Lloyd George W.71	EVP, Investments &CLO	Sell	135,426	$38.34	$5,192,656.17	-84.9%	+17.5%	-
Nov 17, 2025	Coyne Terrance P.75	EVP &CFO	Sell	69,594	$39.30	$2,735,329.16	-8.2%	+16.0%	-
Aug 11, 2025	Norden Gregory	Director	Sell	33,500	$36.23	$1,213,748.55	-14.7%	+6.5%	-
Jan 4, 2024	Riggs Rory B67	-	Sell	470,000	$28.13	$13,222,861.61	-58.7%	+3.6%	-7.1%
Dec 29, 2023	Avara Management Ltd57	10% Owner	Sell	65,803	$28.04	$1,845,405.65	-2.6%	+8.1%	-9.1%
Dec 28, 2023	Avara Management Ltd57	10% Owner	Sell	251,592	$28.17	$7,087,688.26	-4.5%	+8.9%	-8.7%

← PrevPage 2Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC